MTX-132

N/A

Report date: 2024/05/20 15:17:04

Base Information

Drug NameMTX-132
Drug Alias NameMTX-132DAR 4hRS7 Ab-T1000-Exatecan
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > Tetrapeptide linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payload
Mechanisms of ActionDNA topoisomerase I inhibitorsAnti-Trop-2
TargetsDNA topoisomerase ITumor-associated calcium signal transducer 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMultitude Therapeutics IncAbmart IncSun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesMultitude Therapeutics IncSun Yat-Sen UniversityAbmart Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A